ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma"
Episode Synopsis
Dr. Iyad Alnahhas interviews Dr. Carl Koschmann about his and his team's recent manuscript entitled: "Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma" published online in Neuro-Oncology in February 2022. Read the Study
More episodes of the podcast Neuro-Oncology: The Podcast
A transcriptomic atlas of CNS tumors
11/07/2025
Gut microbiome in primary CNS lymphoma
27/06/2025
Germline analysis of diffuse midline glioma
08/06/2025
Radio-Pathomic maps and MR perfusion
18/04/2025
CSF proteomics in glioma
21/03/2025
Vorasidenib in IDH mutant glioma
08/03/2025
In God we trust